Delivery Order SPE2DB22D1106-SPE2DB24FECP9
- Not listed
- This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, for a total ceiling value of $4,702.61. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 13, 2024....
- This federal contract award is for the delivery of LUPRON DEPOT 3.75 MG KITS to the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price of $2,355.55 and an Ultimate Completion Date of July 18, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Lupron Depot 3.75 mg kits to the Defense Logistics Agency (DLA). The $12,115.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of LUPRON DEPOT 3.75 MG KITS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,237.40 and was awarded on July 16, 2025, with a completion date of July 17, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. The awardee is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This contract is not set...
- This federal contract award is for the delivery of LUPRON DEPOT 3.75 MG KITS to the Defense Logistics Agency (DLA), a defense agency. The $3,865.81 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen, as the prime contractor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LUPRON DEPOT 3.75 MG KITS. The contract has a ceiling value of $4,299.59 and a completion date of May 2, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle...
- This federal contract award is for the delivery of Lupron Depot 45 mg 6-month kits to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,299.18 and an ultimate completion date of April 29, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $13,258.87. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 25, 2024. The contract does not have a set-aside designation,...
- This federal contract award is for the supply of LUPRON DEPOT 3.75 MG KITS valued at $2,595.96 to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 28, 2024 with a period of performance through May 29, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of Lupron Depot 3.75 mg kits to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis. The contract has a ceiling value of $4,702.79 and an ultimate completion date of February 24, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The contract...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FECP9Delivery Order
This federal contract award is for the delivery of LUPRON DEPOT 3.75 MG KITS, a pharmaceutical product, to the Defense Logistics Agency (DLA) under Delivery Order SPE2DB22D1106|SPE2DB24FECP9. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This order has a ceiling value of $5,566.23 and an ultimate completion date of March 1, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 2/29/24 |